Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.53 |
| ▸ | PPARA | Q07869 | 5/20 | 0.53 |
| ▸ | F7 | P08709 | 2/20 | 0.47 |
| ▸ | F3 | P13726 | 2/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | PPARD | Q03181 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5228105 | 1.00 | PPARG (0.53) | PPARGPPARAF7F3TERT | |
| SCHEMBL3264779 | 0.93 | PPARG (0.61) | PPARGPPARAF7F3TERT | |
| SCHEMBL3264781 | 0.93 | PPARG (0.61) | PPARGPPARAF7F3TERT | |
| SCHEMBL7207661 | 0.91 | PPARG (0.65) | PPARGPPARAF7F3TERT | |
| SCHEMBL15216622 | 0.91 | PPARG (0.65) | PPARGPPARAF7F3TERT | |
| SCHEMBL29469553 | 0.91 | PPARG (0.65) | PPARGPPARAF7F3TERT | |
| SCHEMBL7207656 | 0.91 | PPARG (0.65) | PPARGPPARAF7F3TERT | |
| SCHEMBL4553754 | 0.91 | PPARG (0.65) | PPARGPPARAF7F3TERT | |
| SCHEMBL13039634 | 0.86 | PPARG (0.63) | PPARGPPARAF7F3TERT | |
| SCHEMBL160884 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2413191-A1 | Actinic-ray- or radiation-sensitive resin composition, resist film therefrom and method of forming pattern therewith | Fujifilm Corporation (JP) | 2012-02-01 | — | — | EP | disclosed |
| EP-1439001-B1 | Process for producing optically active epoxides | TOSOH CORP (JP) | 2007-07-25 | — | — | EP | disclosed |
| EP-1127616-B1 | Catalyst for asymmetric epoxidations of enones and process for producing optically active epoxide employing it | TOSOH CORP (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1366815-B1 | Catalyst for asymmetric epoxidations of enones and process for producing optically active epoxide employing it | TOSOH CORP (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6878835-B2 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2005-04-12 | — | — | US | disclosed |
| EP-1439001-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2004-07-21 | — | — | EP | disclosed |
| US-20040116721-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| US-6680275-B2 | COMPLEX OF OPTICALLY ACTIVE BINAPHTHOL, LANTHANUM TRIISOPROPOXIDE OXIDE, TRIPHENYLPHOSPHINE OXIDE AND CUMENE OR TERT-BUTYL HYDROPEROXIDE; OPTICAL PURITY; REACTIVITY; STABILITY | TOSOH CORPORATION (JP) | 2004-01-20 | — | — | US | disclosed |
| EP-1366815-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2003-12-03 | — | — | EP | disclosed |
| US-20010051737-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-1127616-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-6201123-B1 | FOR ASYMMETRIC EPOXIDATION OF ENONES; GIVES EPOXIDES HAVING AN ENHANCED OPTICAL PURITY | TECHNO POLYMER CO., LTD. (JP) | 2001-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051737-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | SQLE, ENO1, GPX4 | PPARG 1806/4885PPARA 1702/4885F7 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.